510(k) Report

FDA product code · Cardiovascular

Analyzer, Pacemaker Generator Function, Indirect

KREClass II21 CFR 870.3640510(k) required13 decisions since 19800 recalls

13 FDA decisions since 1980. No recall names this code. The most-cited predicate is K915632, named by 4 later devices.

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026 Download the data (CSV)

FIG. A — Illustration, cardiovascular panel

Twenty years of KRE at a glance: how often FDA decides these devices, how long 510(k) reviews take, how often they are recalled, and how many adverse event reports name the code.

FDA decisions per year · KRE

1in 2011

2008: 12011: 1
2007high 1 (2008) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · KRE

Too few KRE 510(k)s in any year since 2007 to give a median.

Recalls per year · KRE

No recall names KRE since 2007.

Adverse event reports per year · KRE

2in 2023

2014: 22015: 12016: 72017: 12018: 62019: 32020: 42021: 142022: 22023: 2
2007high 14 (2021) · low 0 (2007)2025

MAUDE reports naming product code KRE, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—00
20081—00
20090—00
20100—00
20111—00
20120—00
20130—00
20140—02
20150—01
20160—07
20170—01
20180—06
20190—03
20200—04
20210—014
20220—02
20230—02
20240—00
20250—00
20260—0—
FIG. 1 — KRE by year, 2007–2026Sources: FDA decision databases, recall and enforcement reports, MAUDE · Data through Oct 25, 2026

Planning a device in KRE? A 510(k) Report ranks candidate predicates in this code by lineage, citations and recall history, with the review-time outlook.

See the 510(k) Report